Mergers & Acquisitions - Metamark Genetics


Current filters:

Metamark Genetics

Popular Filters

838 to 846 of 846 results

Takeda takes stake in USA-based Fate Therapeutics to expand in regenerative medicines


Japan’s largest drugmaker Takeda Pharmaceutical (TSE: 4502) has made an equity investment in privately-held…

BiotechnologyFate TherapeuticsMergers & AcquisitionsPharmaceuticalTakeda Pharmaceuticals

Elan Drug Tech to merge into Alkermes in $960 million deal to create CNS leader


US drugmaker Alkermes (Nasdaq: ALKS) and Ireland-based Elan Corp (NYSE: ELN) revealed this morning that…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsNeurologicalPharmaceutical

Bayer would consider “merger of equals” for its health care unit, CEO tells Bloomberg


Although German drugs and crop sciences major Bayer AG (BAY: DE) is fine with doing nothing, a “merger…

BayerMergers & AcquisitionsPharmaceutical

Teva to buy Japanese generic drugmaker Taiyo?


According to Japan’s leading financial newspaper, The Nikkei, Israeli generics drug giant Teva Pharmaceutical…

Asia-PacificGenericsMergers & AcquisitionsTaiyo PharmaTeva Pharmaceutical Industries

Grifols closer to Talecris acquisition, but must sell assets


Spanish health care group Grifols (GRLS: MC) and acquisition target Talecris Biotherapeutics (Nasdaq:…

GrifolsMergers & AcquisitionsPharmaceuticalTalecris

Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body


The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE:…

Baxter HealthcareGenericsHikma PharmaceuticalsLegalMergers & Acquisitions

Johnson & Johnson to buy orthopedic device maker Synthes for $21.3 billion


Following earlier speculation, this morning, US diversified health care giant Johnson & Johnson (NYSE:…

Johnson & JohnsonMergers & AcquisitionsPharmaceuticalSynthes

838 to 846 of 846 results

Back to top